Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Prediction of ICD Candidacy After Anterior Myocardial Infarction

NCT: NCT05285631 · COMPLETED

NCT IDNCT05285631
StatusCOMPLETED
Start Date2022-05-31
Completion2026-05-31
SponsorAswan University (OTHER)
First posted
Last updated

Brief Summary

Despite the advances of pharmacologic and interventional therapies, sudden (or arrhythmic) cardiac death remains very high in the early weeks-to-months after an acute myocardial infarction (MI).The majority of cardiac arrests occur in patients who have large infarctions resulting in extensive myocardial damage, which is translated into lower left ventricular ejection fraction (LVEF). Hence, low LVEF remains -to the current time- the most robust predictor for post MI sudden (and presumably arrhythmic) death; and is the determinant for implantable cardioverter defibrillator (ICD) candidacy for primary prevention as per clinical practice guidelines.ICD significantly and effectively reduced ventricular arrhythmia (VA)-mediated cardiac deaths among these patients.

Frequently Asked Questions

What is Early Prediction of ICD Candidacy After Anterior Myocardial Infarction?

Early Prediction of ICD Candidacy After Anterior Myocardial Infarction is a clinical trial registered under NCT05285631. Current status: COMPLETED.

What is the status of NCT05285631?

The current status of NCT05285631 (Early Prediction of ICD Candidacy After Anterior Myocardial Infarction) is: COMPLETED.

When did Early Prediction of ICD Candidacy After Anterior Myocardial Infarction start?

Early Prediction of ICD Candidacy After Anterior Myocardial Infarction started on 2022-05-31.

Related Devices

PMA P010031Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)Medtronic Cardiac Rhythm Disease Management PMA P030054Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)ABBOTT MEDICAL PMA P060027Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)MicroPort CRM USA, Inc. PMA P880006Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)St. Jude Medical, Inc. PMA P220012Implantable cardioverter defibrillator (non-CRT)Medtronic, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑